[The dystonias--botulinum toxin, deep brain stimulation, pharmacotherapy, motor training]
- PMID: 17221824
- DOI: 10.1024/0040-5930.64.1.41
[The dystonias--botulinum toxin, deep brain stimulation, pharmacotherapy, motor training]
Abstract
Despite great advances in the understanding of the dystonias, treatment for most patients remains symptomatic. Botulinum neurotoxin (BoNT) is the treatment of choice for focal dystonias. Selected issues related to the use of BoNT are highlighted with pertinent illustrations. In certain focal, mainly in generalised dystonias BoNT may not be sufficient or appropriate. Besides BoNT pharmacotherapy, nowadays increasingly deep brain stimulation, psychotherapy, physio- and occupational therapy approaches can be included in the management of dystonic patients. The review focuses on experiences with established management guidelines and new developments in the treatment of dystonias.
Similar articles
-
[Medical aspects of the medical treatment in dystonia].Bull Acad Natl Med. 2011 Apr-May;195(4-5):935-50. Bull Acad Natl Med. 2011. PMID: 22375361 Review. French.
-
Treatment of dystonia.Lancet Neurol. 2006 Oct;5(10):864-72. doi: 10.1016/S1474-4422(06)70574-9. Lancet Neurol. 2006. PMID: 16987733 Review.
-
The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.Int J Neurosci. 2011;121 Suppl 1:44-56. doi: 10.3109/00207454.2011.558260. Int J Neurosci. 2011. PMID: 21348790 Clinical Trial.
-
Therapeutic challenges in dystonia.Neurol Clin. 2010 Nov;28(4):927-40. doi: 10.1016/j.ncl.2010.03.020. Epub 2010 Jul 14. Neurol Clin. 2010. PMID: 20816271 Review.
-
New approaches in the treatment of the dystonias.Klin Wochenschr. 1990 Oct 3;68(19):935-41. doi: 10.1007/BF01646651. Klin Wochenschr. 1990. PMID: 2232624 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
